SQZ Biotechnologies Co (OTC:SQZB)
Health Care/Life Sciences • Biotechnology
CIK 1604477
Company
SQZ Biotechnologies Co. is a clinical-stage biotechnology company, which engages in developing cell therapies for patients with cancer, infectious diseases, and other serious conditions. It operates through SQZ cell therapy platform, which uses membrane disruption to deliver material into cells. The company was founded by Robert S. Langer Jr., Klavis F. Jensen, Agustin Lopez Marquez, and Armon Sharei in March 2013 and is headquartered in Watertown, MA.
Address
200 Arsenal Yards Boulevard
Suite 210
Watertown, Massachusetts 02472
200 Arsenal Yards Boulevard
Suite 210
Watertown, Massachusetts 02472
Employees
53
53
Stock Info
Close
$0.0482
$0.0482
Day Range
0.0480 - 0.0574
0.0480 - 0.0574
52 Week Range
0.0101 - 0.8188
0.0101 - 0.8188
Average volume
233.22K
233.22K
Short Interest
797.41K (06/30/23)
797.41K (06/30/23)
% of Float Shorted
3.64%
3.64%
Market Cap
$1.42M
$1.42M
Revenue
$21.48M
$21.48M
Net Income
N/A
N/A
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Chairman Amy L Schulman |
Chief Executive Officer & Director Howard Bernstein MD, PhD |
Independent Director Klavis F Jensen PhD |
Independent Director Marc W Elia |
Independent Director Pushkal P Garg MD |
Independent Director Sapna R Srivastava PhD |
Independent Director Marc Schegerin MD, MBA |
Independent Director Paul B Bolno MD, MBA |
Independent Director Bernard Coulie MD, PhD |
Independent Director Patrick Volkert Vink MD, MBA |
SEC filings
Date | Form | Event |
---|---|---|
13 Feb, 2024 | SC 13G/A | |
9 Feb, 2024 | SC 13G/A | |
23 Jan, 2024 | DEFM14A | |
12 Jan, 2024 | PREM14A | |
4 Jan, 2024 | 15-12G | |
22 Dec, 2023 | 8-K | |
1 Dec, 2023 | EFFECT | |
30 Nov, 2023 | S-8 POS | |
30 Nov, 2023 | POS AM | |
8 Nov, 2023 | 10-Q | |
2 Oct, 2023 | 8-K | CEO Change |
15 Sep, 2023 | 8-K | |
10 Aug, 2023 | 10-Q | |
25 Jul, 2023 | 8-K | |
19 Jul, 2023 | 25-NSE | |
7 Jul, 2023 | 8-K | |
3 Jul, 2023 | 8-K | |
15 Jun, 2023 | 4 | |
15 Jun, 2023 | 8-K | |
15 Jun, 2023 | 4 | |
15 Jun, 2023 | 4 | |
15 Jun, 2023 | 4 | |
15 Jun, 2023 | 4 | |
15 Jun, 2023 | 4 | |
15 Jun, 2023 | 4 | |
15 Jun, 2023 | 4 | |
15 Jun, 2023 | 4 | |
10 May, 2023 | 10-Q | |
5 May, 2023 | ARS | |
26 Apr, 2023 | DEF 14A | |
26 Apr, 2023 | DEFA14A | |
10 Apr, 2023 | PRE 14A | |
10 Apr, 2023 | 8-K | |
22 Mar, 2023 | 10-K | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | SC 13G/A | |
13 Feb, 2023 | SC 13G/A | |
26 Jan, 2023 | 4 | |
26 Jan, 2023 | 4 | |
26 Jan, 2023 | 4 | |
26 Jan, 2023 | 4 | |
26 Jan, 2023 | 4 | |
18 Jan, 2023 | 8-K | |
6 Dec, 2022 | 8-K | |
30 Nov, 2022 | 8-K | |
9 Nov, 2022 | 10-Q | |
6 Sep, 2022 | 8-K | |
16 Aug, 2022 | 4 | |
4 Aug, 2022 | 10-Q | |
13 Jul, 2022 | 4 | |
11 Jul, 2022 | 8-K | |
5 Jul, 2022 | 4 | |
5 Jul, 2022 | 4 | |
5 Jul, 2022 | 4 | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 8-K | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 4 | |
3 Jun, 2022 | 4 | |
3 Jun, 2022 | 3 | |
31 May, 2022 | 8-K | |
27 May, 2022 | 4 | |
19 May, 2022 | 8-K | |
10 May, 2022 | 10-Q | |
26 Apr, 2022 | DEFA14A | |
26 Apr, 2022 | DEF 14A | |
16 Mar, 2022 | 10-K | |
15 Feb, 2022 | 4 | |
15 Feb, 2022 | 4 | |
15 Feb, 2022 | 4 | |
15 Feb, 2022 | 4 | |
15 Feb, 2022 | 4 | |
15 Feb, 2022 | 4 | |
14 Feb, 2022 | SC 13G/A | |
14 Feb, 2022 | SC 13G/A | |
14 Feb, 2022 | SC 13G/A | |
11 Feb, 2022 | SC 13D/A | |
10 Feb, 2022 | SC 13G/A | |
9 Feb, 2022 | SC 13G/A | |
4 Feb, 2022 | SC 13G | |
24 Jan, 2022 | 8-K | |
13 Jan, 2022 | 4 | |
4 Jan, 2022 | 4 | |
4 Jan, 2022 | 4 | |
23 Dec, 2021 | 4 | |
22 Dec, 2021 | 4 | |
15 Dec, 2021 | 4 | |
9 Dec, 2021 | 8-K | |
2 Dec, 2021 | 8-K | |
18 Nov, 2021 | EFFECT | |
18 Nov, 2021 | 8-K/A | |
16 Nov, 2021 | CORRESP | |
16 Nov, 2021 | 3 | |
15 Nov, 2021 | UPLOAD | |
12 Nov, 2021 | S-3 | |
10 Nov, 2021 | 10-Q | |
4 Nov, 2021 | 8-K | CEO Change |
26 Oct, 2021 | 8-K | |
13 Sep, 2021 | 8-K | |
2 Sep, 2021 | 8-K | |
9 Aug, 2021 | SC 13G | |
4 Aug, 2021 | 10-Q | |
29 Jul, 2021 | 8-K/A | |
1 Jul, 2021 | 3 | |
1 Jul, 2021 | 4 | |
1 Jul, 2021 | 4 | |
1 Jul, 2021 | 8-K | |
1 Jul, 2021 | 3 | |
17 Jun, 2021 | 4 | |
17 Jun, 2021 | 8-K | |
17 Jun, 2021 | 4 | |
17 Jun, 2021 | 4 | |
17 Jun, 2021 | 4 | |
17 Jun, 2021 | 4 | |
17 Jun, 2021 | 4 | |
17 Jun, 2021 | 4 | |
4 Jun, 2021 | 8-K | |
11 May, 2021 | 10-Q | |
26 Apr, 2021 | DEF 14A | |
26 Apr, 2021 | DEFA14A | |
1 Apr, 2021 | 4/A | |
18 Mar, 2021 | 10-K | |
2 Mar, 2021 | 4 | |
25 Feb, 2021 | 8-K | |
25 Feb, 2021 | 4 | |
25 Feb, 2021 | 4 | |
25 Feb, 2021 | 4 | |
25 Feb, 2021 | 4 | |
25 Feb, 2021 | 4 | |
25 Feb, 2021 | 4 | |
25 Feb, 2021 | 4 | |
19 Feb, 2021 | SC 13G | |
16 Feb, 2021 | SC 13G/A | |
16 Feb, 2021 | SC 13G | |
12 Feb, 2021 | 424B4 | |
11 Feb, 2021 | EFFECT | |
9 Feb, 2021 | CORRESP | |
9 Feb, 2021 | 8-K | |
9 Feb, 2021 | CORRESP | |
9 Feb, 2021 | S-1 | |
8 Feb, 2021 | UPLOAD | |
1 Feb, 2021 | DRS | |
29 Jan, 2021 | DRSLTR | |
12 Jan, 2021 | 4 |
Last update:2024-03-06 13:14:27.419693
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.